Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions.
Antibodies contain a conserved glycosylation site that has emerged as a target for the modulation of antibody effector functions. The crystal structure of a biosynthetic intermediate of human IgG1, bearing immature oligomannose-type glycans and reported to display increased antibody-dependent cellul...
Autors principals: | Crispin, M, Bowden, T, Coles, C, Harlos, K, Aricescu, A, Harvey, D, Stuart, D, Jones, E |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2009
|
Ítems similars
-
Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design
per: Bowden, T, et al.
Publicat: (2008) -
Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity
per: Calow, J, et al.
Publicat: (2016) -
Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies
per: Yu, X, et al.
Publicat: (2013) -
Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis
per: Bowden, T, et al.
Publicat: (2012) -
Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
per: Fry, SA, et al.
Publicat: (2006)